Print

Angiotech Pharmaceuticals, Inc. (ANPI) Announces Financial Results for the Fourth Quarter Ended December 31, 2012  
3/29/2013 6:40:30 AM

VANCOUVER, March 28, 2013 /PRNewswire/ - Angiotech Pharmaceuticals, Inc. ("Angiotech") announced that it released its financial results for the fourth quarter ended December 31, 2012.

Selected recent developments and highlights include:

* Sale of Interventional Products Business to Argon Medical Devices, Inc. On March 25, 2013, we announced that we entered into a definitive agreement to sell certain of our subsidiaries, comprising Angiotech's Interventional Products Business to Argon Medical Devices, Inc., a Delaware corporation ("Argon"), which is a portfolio company of RoundTable, for $362.5 million in cash consideration.

//-->